Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1121 of 6351
-
Could transplanted islets free diabetics from insulin?
Disease control OngoingCity of Hope National Medical Center, located in Duarte, CA, is hosting a clinical study on islet cell transplantation, an experimental procedure being evaluated as a treatment for patients with type 1 diabetes. Islet cell transplantation involves taking insulin-producing cells f…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New combo therapy aims to shrink tough rectal tumors before surgery
Disease control OngoingObjective tumour response rate to FOLFOXIRI to pre-operative therapy.
Phase 2 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Engineered T-Cells take on tough lymphoma in early trial
Disease control OngoingThis phase I trial studies the side effects and best dose of genetically modified T-cells following peripheral blood stem cell transplant in treating patients with recurrent or high-risk non-Hodgkin lymphoma. Giving chemotherapy before a stem cell transplant helps stop the growth…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Common antibiotic may shield Kids' hearts from kawasaki disease damage
Disease control OngoingKawasaki disease (KD) affects infants and young children causing inflammation of the skin and blood vessels including the coronary arteries of the heart. Despite the currently available therapy, about one third of children develop enlargement of the coronary arteries that can lea…
Phase 2 • Sponsor: Hawaii Pacific Health • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Head-to-Head chemo showdown for rare lymphoma
Disease control By invitation onlyThere is no data comparing the effectiveness of the 4 most relevant first-line therapy programs for peripheral T-cell lymphomas (CHOEP, CHOP, CHEP-BV, CHP-BV) in a single study. For the first time, the effectiveness and toxicity of various first-line PTCL therapy programs in pat…
Phase 3 • Sponsor: N.N. Petrov National Medical Research Center of Oncology • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New eye scans may catch glaucoma before vision loss
Diagnosis Recruiting nowThe specific aims of the clinical studies are to: * Develop a directional high-resolution OCT and OCT angiography prototype to improve imaging of structure and perfusion. * Validate wide-field OCT and OCT angiography parameters to improve early glaucoma detection. * Simulate vis…
Sponsor: Oregon Health and Science University • Aim: Diagnosis
Last updated Sep 10, 2026 01:00 UTC
-
Blood cancer drug ibrutinib gets Long-Term safety check in 700-Patient study
Disease control Recruiting nowThe purpose of this study is to collect long-term safety and efficacy data for participants treated with ibrutinib and to provide ongoing access to ibrutinib for participants who are currently enrolled in ibrutinib studies that have been completed according to the parent protocol…
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Early rehab after heart attack may save lives and cut hospital visits
Disease control OngoingAn intervention study with longitudinal follow-up of patients with coronary artery disease undergoing early cardiac rehabilitation is designed.
Sponsor: Haukeland University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Money smarts may boost HIV med adherence in ugandan teens
Disease control OngoingThe goal of Suubi+Adherence is to examine the impact and cost associated with an innovative intervention to increase adherence to HIV treatment for HIV-infected adolescents. Multiple intervention studies by our team in Rakai and Masaka Districts of southern Uganda with AIDS-orpha…
Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New combo therapy shows promise for HPV throat cancer patients
Disease control CompletedThis phase II trial studies how well radiation therapy and docetaxel work in treating patients with human papillomavirus (HPV)-related oropharyngeal cancer. Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in chemotherapy, such as docetaxel, work in diffe…
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Targeted drug LDK378 takes aim at rare ROS1-driven lung cancer
Disease control CompletedROS1 is a receptor tyrosine kinase with constitutive kinase activity. ROS1 was previously discovered in cell lines where ROS1 fused with other proteins to act as a driver oncogene. In 2007, Rikova et al reported ROS1 fusion as driver mutations in NSCLC cell line (HCC78; SLC34A2-R…
Phase 2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Can your own stem cells repair heart attack damage?
Disease control CompletedThrough the injection of Hearticellgram-AMI into acute myocardial infarction patients who are the primary targets of the drug, long term efficacy in the improvement of the left ventricle ejection fraction upon the first cell treatment is to be evaluated and compared with the curr…
Phase 3 • Sponsor: Pharmicell Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Could chemo before surgery spare colon cancer patients from extra cycles?
Disease control CompletedThe purpose of this study is to compare 3 cycles of neoadjuvant (preoperative) chemotherapy + operation with the standard treatment of locally advanced colon cancer, which is operation + 8 cycles of (adjuvant) chemotherapy. Patients receiving neoadjuvant chemotherapy may not nee…
Phase 3 • Sponsor: Vejle Hospital • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Your DNA might predict radiation side effects
Knowledge-focused CompletedBackground of the study: Swallowing dysfunction and xerostomia are the most frequently reported radiation-induced side effects (RISE) after (chemo) radiation ((CH) RT) in head and neck cancer (HNC) patients and have a major impact on the general dimensions of quality of life (Qo…
Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Could a pill boost chemo for tough lymphoma?
Disease control OngoingThis randomized phase II trial studies how well rituximab and combination chemotherapy with or without lenalidomide work in treating patients with newly diagnosed stage II-IV diffuse large B cell lymphoma. Monoclonal antibodies, such as rituximab, may interfere with the ability o…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New study tests two-step surgery to delay menopause while cutting ovarian cancer risk
Prevention OngoingThe goal of this clinical research study is to compare ovarian cancer screening, risk-reducing salpingo-oophorectomy (RRSO), and prophylactic salpingectomy with delayed oophorectomy (PSDO). The safety of RRSO and PSDO will also be studied. Ovarian cancer screening does not invol…
Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 12:07 UTC
-
New hope: drug cocktail aims to stop colon cancer recurrence
Prevention OngoingThe investigators hypothesize that the combination of eflornithine and sulindac will be effective in reducing a three-year event rate of adenomas and second primary colorectal cancers in patients previously treated for Stages 0 through III colon or rectal cancer.
Phase 3 • Sponsor: SWOG Cancer Research Network • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
Adult leukemia patients get Kid-Style chemo combo in new trial
Disease control OngoingThe purpose of the study is to find out whether the combination of chemotherapy drugs that are routinely used in children with ALL, will be safe and effective in treating adult patients with ALL. The standard treatment for adults with ALL consists of many chemotherapy drugs that …
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 18:20 UTC
-
Pre-Surgery drug cocktail aims to wipe out rectal cancer
Disease control Stopped earlyThis phase II trial studies how well bevacizumab, fluorouracil, leucovorin calcium, and oxaliplatin before surgery works in treating patients with stage II-III rectal cancer. Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the abil…
Phase 2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Can a different opioid reduce Post-C-Section itching?
Symptom relief CompletedThe primary objectives of this study are to compare the efficacy of pain relief between epidural oxycodone and epidural morphine for postoperative analgesia after elective caesarean section and to compare the incidence and severity of pruritus. Secondary objectives are to compare…
Phase 3 • Sponsor: KK Women's and Children's Hospital • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC